Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Mainz Biomed (MYNZ)

  • Technical Exchange News
  • Jan. 15, 2025, 19:07 UTC
  • 29

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Syros Pharmaceuticals (SYRS)

  • Technical Exchange News
  • Jan. 15, 2025, 02:39 UTC
  • 21

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Syros Pharmaceuticals (SYRS)

  • Technical Exchange News
  • Jan. 14, 2025, 19:17 UTC
  • 22

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

TC BioPharm Holdings (TCBP)

  • Technical Exchange News
  • Jan. 14, 2025, 02:50 UTC
  • 29

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

ProMIS Neurosciences Inc (PMN)

  • Technical Exchange News
  • Jan. 14, 2025, 02:50 UTC
  • 21

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Lexicon Pharmaceuticals Inc. (LXRX)

  • Technical Exchange News
  • Jan. 14, 2025, 02:49 UTC
  • 23

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Incannex Healthcare Ltd (IXHL)

  • Technical Exchange News
  • Jan. 14, 2025, 02:49 UTC
  • 26

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

TC BioPharm Holdings (TCBP)

  • Technical Exchange News
  • Jan. 13, 2025, 19:25 UTC
  • 25

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

ProMIS Neurosciences Inc (PMN)

  • Technical Exchange News
  • Jan. 13, 2025, 19:25 UTC
  • 24

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Lexicon Pharmaceuticals Inc. (LXRX)

  • Technical Exchange News
  • Jan. 13, 2025, 19:24 UTC
  • 27

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 126
  • 127
  • 128
  • 129
  • 130
  • Next

Search

News categories

  • Technical Exchange News(9391)
  • Event(407)
  • SEC News(153820)
  • FDA Approval(8775)
  • Company Report(721)
  • Business News(104842)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin